Linda S. Palczuk

Linda S. Palczuk has been a member of the Avadel Board of Directors since July 2018. Since September 2019, Linda has been the Chief Operating Officer and a Director of Envara Health, Inc., a medical nutrition technology company. Prior to Envara Health, Linda was the Chief Operating Officer of Verrica Pharmaceuticals, Inc., a late-stage biopharmaceutical company focused on medical dermatology products, and before that, she was President and Chief Executive Officer at Osiris Therapeutics, Inc., a regenerative medicines biotechnology company. Linda also had an extensive and successful 30-year career with AstraZeneca Pharmaceuticals and its legacy companies, serving in senior-level commercial and general management roles, including Vice President, Established Brands; Vice President, Global Commercial Excellence; Vice President, Sales & Marketing; and Vice President, Sales. Linda received a BA in biology from Franklin and Marshall College and an MBA degree from the Alfred Lerner College of Business and Economics at the University of Delaware.